课题基金 / 基金详情

Alternative splicing in Ras transformed cells

Alternative splicing in Ras transformed cells
Ras 转化细胞中的选择性剪接
批准号:
8553150
负责人:
Ji Luo
金额:
$13.47万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Ji Luo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
BACKGROUNDThrough a RNAi synthetic lethal screen we have identified a number of key mRNA splicing factors to be required for the viability of Ras mutant cancer cells.PURPOSEIn this project we aim to address the following questions: 1) the mechanism by which depletion of a subset of mRNA splicing factors causes synthetic lethality with Ras mutation; 2) which cellular proteins are differentially spliced in Ras mutant cells; 3) how the changes in mRNA splicing pattern in Ras mutant cells affect their viability compared to Ras wild type cells.SIGNIFICANT MATERIALS AND METHODS1) shRNAs that target splicing factors. 2) RNA-seq protocol for quantifying mRNA splicing pattern changes.FY2012 ACCOMPLISHMENTWe have validated shRNAs that target a number mRNA splicing factors that are identified to be synthetically lethal with KRAS. We have generated cell lines stably expressing rescue cDNAs to these factors. We have carried out RNA-seq experiments to characterize mRNA splicing patters in KRAS wild type and mutant cells with or without splicing factor knockdown. We have identified candidate genes whose proper splicing and expression are critical for the viability of KRAS mutant cells and we are currently investigate the mechanisms underlying such dependency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ras oncogene induced protein SUMOylation changes
Effect of the Ras oncogene on genomic stability
Ras oncogene induced protein SUMOylation changes
Pooled shRNA screens for target discoveries in cancer
海外基金